falsefalse

My Treatment Approach: Graft vs Host Disease - Episode 3

First-Line Treatment Options for Patients with Chronic GVHD

Nelson J. Chao, MD, MBA, explains the frontline treatment options for chronic GVHD, and when to consider restarting an immunosuppressive regimen.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Patient Profile Presentation: A 60-Year-Old Man with Graft-Versus-Host Disease (GVHD)
    EP. 2: Staging of Chronic GVHD
    Now Viewing
    EP. 3: First-Line Treatment Options for Patients with Chronic GVHD
    EP. 4: Patient Profile Presentation: A 67-Year-Old Woman with GVHD
    EP. 5: Investigational Systemic Treatment Options for GVHD
    EP. 6: Treatment Sequencing and Future of GVHD
    EP. 7: Patient Profile Presentation: A 44-Year-Old Woman With Acute Myeloid Leukemia and Graft-Versus-Host Disease (GVHD)
    EP. 8: Indications for Allogeneic Stem Cell Transplantation in the Treatment of Myeloid Malignancies
    EP. 9: Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant
    EP. 10: Currently Available Options for GVHD Prophylaxis
    EP. 11: Comparing Acute and Chronic GVHD
    EP. 12: Available Frontline Treatment Options for Patients With Acute GVHD
    EP. 13: Current Treatment Options for Patients with Steroid-Refractory Acute GVHD

    Related Content:

    My Treatment Approach: Graft vs Host DiseaseInsightsInsights Video Series
    Looking Ahead and Final Thoughts in IO Sequencing in Advanced EC
    Future of Gynecologic Oncology: Integrating Antibody-Drug Conjugates and Novel Combinations Into the IO Sequencing Paradigm for Advanced EC
    Treatment Landscape for Advanced NETs
    x